Sana Biotechnology Inc (SANA)

[tw0122]

, a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor conferences in December. The presentations will feature a business overview and update by Steve Harr, Sana’s President and Chief Executive Officer.The webcasts will be accessible on the Investor Relations page of Sana’s website at https://www.globenewswire.com/Tracker?data=j1CZt8aJ3vRIzQKEKkKsvwyGOhmoySrB6li90vptNVrR4yd0q6Gg8zFx78pqHwU5adT3eFQ2yRBfXg7ioNgxNg==. A replay of each presentation will be available at the same location for 30 days following the conference.
Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We share a vision of repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available to patients. We are a passionate group of people working together to create an enduring company that changes how the world treats disease. Sana has operations in Seattle, WA, Cambridge, MA, and South San Francisco, CA. For more information about Sana Biotechnology, please